3,731
Views
5
CrossRef citations to date
0
Altmetric
Brief Report

Upadacitinib for the treatment of concomitant psoriasis and atopic dermatitis: a case series

, , , , , & show all
Article: 2183729 | Received 03 Feb 2023, Accepted 16 Feb 2023, Published online: 27 Feb 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Matteo Megna, Luca Potestio, Angelo Ruggiero, Sara Cacciapuoti, Francesco Maione, Marco Tasso, Francesco Caso & Luisa Costa. (2023) JAK Inhibitors in Psoriatic Disease. Clinical, Cosmetic and Investigational Dermatology 16, pages 3129-3145.
Read now
Diego Orsini, Luciano Ibba, Alessandra Narcisi, Pasquale Frascione, Alessia Pacifico, Mario Valenti, Antonio Costanzo & Luigi Gargiulo. (2023) Long-term management of pediatric psoriasis with ixekizumab: a case report. Journal of Dermatological Treatment 34:1.
Read now

Articles from other publishers (3)

Alba Guglielmo, Maria Ludovica Deotto, Luigi Naldi, Giuseppe Stinco, Alessandro Pileri, Bianca Maria Piraccini, Anna Belloni Fortina & Andrea Sechi. (2023) Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective. Dermatology Reports.
Crossref
Francisco Navarro-Triviño, Sara Alcantara-Luna, Javier Domínguez-Cruz, Manuel Galán-Gutiérrez, Ricardo Ruiz-Villaverde, José-Juan Pereyra-Rodriguez & José-Carlos Armario-Hita. (2023) Upadacitinib for moderate to severe atopic dermatitis. Immunotherapy.
Crossref
. (2023) Multiple drugs. Reactions Weekly 1953:1, pages 285-285.
Crossref